Health Catalyst DEF 14A: Executive Compensation Details
Ticker: HCAT · Form: DEF 14A · Filed: May 19, 2025 · CIK: 1636422
| Field | Detail |
|---|---|
| Company | Health Catalyst, Inc. (HCAT) |
| Form Type | DEF 14A |
| Filed Date | May 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, governance
TL;DR
Health Catalyst dropped its 2025 proxy statement, showing exec comp details for 2024. Check it for equity awards.
AI Summary
Health Catalyst, Inc. filed its DEF 14A on May 19, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted to both principal executive officers (PEO) and non-PEO named executive officers, with specific values for outstanding and unvested awards as of year-end 2023 and 2024.
Why It Matters
This filing provides transparency into how Health Catalyst compensates its top executives, which can influence investor perception and corporate governance.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) providing information on executive compensation and is not indicative of immediate financial risk.
Key Numbers
- 2024 — Fiscal Year End (The period for which executive compensation is reported.)
- 2023 — Previous Fiscal Year End (Provides comparative data for executive compensation.)
Key Players & Entities
- Health Catalyst, Inc. (company) — Filer of the DEF 14A
- 2024-12-31 (date) — Fiscal year end for compensation details
- 2025-05-19 (date) — Filing date of the DEF 14A
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose of this DEF 14A filing is to provide detailed information regarding the company's executive compensation, director compensation, and other corporate governance matters for the fiscal year ending December 31, 2024.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on May 19, 2025.
What fiscal year does the compensation information in this filing primarily cover?
The compensation information in this filing primarily covers the fiscal year ending December 31, 2024.
What types of equity awards are detailed in the filing?
The filing details equity awards granted, outstanding, and unvested for both Principal Executive Officers (PEO) and Non-PEO Named Executive Officers as of the end of the fiscal years 2023 and 2024.
What was Health Catalyst, Inc.'s former company name?
Health Catalyst, Inc.'s former company name was HQC Holdings, Inc., with a date of name change on March 12, 2015.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 19, 2025 regarding Health Catalyst, Inc. (HCAT).